This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $608,731 to Brown University to conduct research on the impact of Medicare and Medicaid financial policies on post-acute and long-term care for persons living with dementia. The project will leverage 15 years of Medicare claims and clinical assessment data to examine how changes in healthcare financing have affected long-term care utilization and health outcomes for the 6.7 million...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $2,238,104 to Brown University to conduct research on prescribing cascades among nursing home residents with Alzheimer's disease and related dementias (ADRD). The key objectives are to identify risk factors for prescribing cascades, estimate the effects of precipitant medication use on resultant medication use, and quantify the impacts of prescribing cascades on adverse outcomes like...
This $318,000 federal Project Grant award was provided by the National Institute on Aging (NIA) under the Aging Research federal grant program (CFDA 93.866) with a start date of September 17, 2024 and an end date of August 31, 2026. The grant will fund a study to investigate the epidemiology and clinical consequences of cardiometabolic medication substitution that occurs when older adults transition from acute hospital care to skilled nursing facilities (SNFs). The research aims to determine the...
This $243,000 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will fund a 5-year study to address the issue of potentially inappropriate medication (PIM) use among older adults with Alzheimer's disease and related dementias (ADRD) receiving home health care. The key objectives are to: 1) Identify factors and barriers/facilitators associated with routine PIM deprescribing practices for ADRD patients in home health care, using a mixed methods approach; and...
The National Institute on Aging (NIA), under the Aging Research (CFDA 93.866) Federal Grant Program, awarded a $199,375 project grant to Brown University. The project aims to examine whether hospices specializing in long-term care (LTC) settings provide better care to beneficiaries with Alzheimer's and related dementias (ADRD) compared to non-LTC hospices. Key objectives include: 1) describing individual, facility, and neighborhood-level characteristics associated with receiving care from LTC...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) provides $116,338 to Brown University to analyze the impact of civil unrest on healthcare utilization and mental healthcare for older adults enrolled in traditional Medicare. The study will track healthcare metrics such as preventable hospitalizations, emergency department visits, and primary care visits in Minneapolis, Baltimore, and Ferguson for 6 months before and 24-36 months after civil unrest...
This Project Grant award of $4,787,820, provided by the National Institute on Aging (CFDA 93.866 Aging Research), supports a research project titled "PREDICT ADRD: PREDICTING THE EFFECTS OF DIAGNOSIS IN INDIVIDUALS ACROSS COUNTRIES AND TIME IN ADRD". The primary goals are to: 1) examine the relationship between cognitive decline and workforce exit for older adults in the U.S., England, and 28 European countries; 2) assess the concordance between survey-based cognitive tests and...
This Project Grant award of $794,956 from the National Institute on Aging (NIA) Aging Research program (CFDA 93.866) aims to evaluate the effectiveness of Transitional Care Management (TCM) and Chronic Care Management (CCM) services in improving health outcomes and reducing healthcare costs for older adult Medicare beneficiaries. The research will employ a target trial emulation approach to compare TCM and CCM services to usual care, with a focus on outcomes such as home time, survival, and...
This Project Grant award of $674,227 from the National Institute on Aging (CFDA 93.866 - Aging Research) will fund a study at New York University to examine the impact of the 340B Drug Pricing Program on medication utilization, health outcomes, and disparities in the Medicare population. The research aims to evaluate how the growth of the 340B program has affected Medicare Part D medication volumes, characteristics, guideline-concordant use, adherence, and health outcomes, with a focus on...
This $2,497,615 federal Project Grant award, funded by the National Institute on Aging under the Aging Research program (CFDA 93.866), aims to evaluate the impact of new Medicare home health agency (HHA) payment policies on healthcare utilization and outcomes for Medicare beneficiaries with Alzheimer's disease and related dementias (ADRD). The project has three key objectives: 1) characterizing changes in the ADRD beneficiary population eligible for HHA services, 2) evaluating the effect of...